Henry Wu

Chief Executive Officer

Education

Rutgers University, Ph.D. in Biostatistics
Tsinghua University, BS in Electrical Engineering and Industrial Engineering

Industry Experience

19 years of industry experience, worked at Pfizer and Roche
2003-2010 Founded a statistical consulting firm in the US
2010-2016 Head of the K&L data and statistics division
2013-2016 COO and CEO of Fountain Medical Development

Achievements

Led and completed more than 25 statistical and analysis projects in FDA/EMA NDA applications.

Leo Sun

Chief Strategy Officer

Education

Army Medical University, PhD in Medicine

Industry Experience

Seven years of clinical surgeon experience. Senior Research Fellow and Project Team Leader, US Naval Medical Research Institute. Associate professor and professor of surgery, US Uniformed Services University of the Health Sciences and Duke University. Director of NIH/Cancer Research Program and Senior Statistician. Senior FDA epidemiologist, review leader, medical device clinical research and post-market inspector.

Professional Awards

China State Council Special Allowance Recipient
China National Science and Technology Progress First Prize and Second Prize Winner 
China Military Science and Technology Progress First Price Winner
Received the US FDA Team Leadership Award in 2016
Published more than 130 papers and books

Wilson Wong

Chief Medical Officer

Education

National Taiwan University, Bachelor Clinical Medicine
National Taiwan University, Internal medicine resident
Vanderbilt University, Clinical Pharmacology, Researcher Fellow
Vanderbilt University, Clinical Medicine Cardiovascular, Clinical Fellow 
Vanderbilt University, Cardiac electrophysiology, Clinical Fellow

Industry Experience

Arkansas Heart Hospital, Cardiovascular and Cardiac Electrophysiology, Senior Cardiologist,
Engaged in the clinical diagnosis and treatment of cardiovascular and cardiac electrophysiology. since 1994

Professional Awards

As a lead investigator, completed and participated in a number of clinical studies for FDA submissions since 1988

Lijun Xiao

Vice President, Regulatory Affairs

Education

Jiamusi Medical College, Bachelor of Pharmacy

Industry Experience

27 years of industry experience, 18 years of regulatory registration experience and 9 years of preclinical research and development experience
Deputy Director, Director and Senior Director of Fountain Medical Pharmaceuticals Registration Department
Successfully filed IND and NDA applications for dozens of chemical and biological products as well as imported drugs. Participated in early clinical development for dozens of innovative drugs as a strategic advisor.
Registered hundreds of pharmaceutical products
Successfully completed US-China dual registration for multiple products

Ziai Wu

Senior Director, Clinical Operation

Education

Peking University School of Medicine, EMBA
Beijing Military Medical College, Bachelor of Clinical Pharmacy

Industry Experience

13 years of clinical operations. Served as CRA, PM, PMD and Operations Director in Novartis, Bayer, George Clinical, Fountain Medical. Served as the clinical project director of oncology and innovative drugs at Fountain Medical, responsible for more than 30 clinical trials of Phase I-III innovative drugs. Extensive experience in Phase I-IV clinical trials, leading clinical operations in cardiovascular, metabolic, neoplastic, neurological, liver, and kidney disease areas.

Mandy Xu

Chief of Bio-Analytical Center

Education

Peking University School of Medicine, Pharm.D.

Industry Experience

11 years of pharmacokinetics research, regulatory experience and bioanalytical management experience, including ADME screening platform, IND DMPK filing, and regulatory bioanalysis to support GLP toxicology and clinical research
Vice President, DMPK and Regulatory Bioanalysis, Pharmaron
Head of Clinical Bioanalytical Testing Laboratory, Pharmaron, with extensive experience in the fields of biotransformation, ADME, and drug-drug interaction
Familiar with pre-clinical and clinical registration of innovative drugs with NMPA and FDA submissions

Yumei Peng

Senior Director, Statistics

Education

Xi'an Jiaotong University, Master of Bioengineering, Genetic Statistics
Xi'an Jiaotong University, Bachelor of Bioengineering

Industry Experience

Over 10 years of biostatistics and programming experience. Pharmaceutical Biostatistics Manager, Senior Manager and Director in MacroStat, Fountain Medical Development. Responsible for statistics and programming of multiple Phase I to IV international and domestic projects (involving different therapeutic areas), 2 US NDA submissions and multiple Chinese NDA submissions.

Pei-Yun Chen

Senior Director, Statistics

Education

North Carolina State University, Ph.D. in Biostatistics
National Chengchi University, MBA in Statistics
National Taiwan University, Bachelor of Mathematics

Industry Experience

Over 18 years of experience in biostatistics industry
 Senior Statistician, Deputy Director of Statistics, Director and Senior Director in Merck, FMD K&L. Participated in multiple FDA NDA submissions across various therapeutic areas.
微信公众号